MDS with del(5q) and associated cKIT D816V positive mastocytosis-Reference-Cited by-同舟云学术

MDS with del(5q) and associated cKIT D816V positive mastocytosis

Published:2012-08 Issue:5 Volume:44 Page:492-493
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Chan Noel,Tan Shuh Ying,Opat Stephen,Shortt Jake

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference5 articles.

1. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies;Pardanani;Blood,2009

2. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathological comparison of del(5q)-positive and -negative cases;Santana-Davila;Leukemia Res,2008

3. Standards and impact of hematopathology in myelodysplastic syndromes;Valent;Oncotarget,2010

4. How I treat patients with advanced mastocytosis;Valent;Blood,2010

5. KIT Inhibitor midostaurin exhibits a high rate of clinically meaningful and durable responses in advanced systemic mastocytosis: report of a fully accrued phase II trial;Gotlib;Blood (ASH Annual Meeting Abstracts),2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aleukemic Variant of Mast Cell Leukemia with del (7)(q31): Rare Case Report of an Elderly Chinese Man;Turkish Journal of Hematology;2023-08-31

2. MDS with 5q deletion and rare cKIT positive mastocytosis: a diagnostic and therapeutic challenge;BMJ Case Reports;2019-04

3. To condition or not to condition—That is the question: The evolution of nonmyeloablative conditions for transplantation;Experimental Hematology;2016-08